Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the odds of a tumor developing. By Nina Agrawal Scientists have made a discovery ...

Medical artificial intelligence (AI) faces a fundamental challenge: uncertainty quantification. Artificial neural networks ...

Matthew Herper covers medical innovation — both its promise and its perils. CHICAGO — Ivonescimab, a drug that combines the activity of two of the best-selling cancer medicines, reduced the risk of ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Also, senators clashed over Trump’s payout fund. Here’s the latest at the end of Thursday. By Matthew Cullen A group of scientists announced a discovery today that may help prevent some people from ...

An experimental lung cancer drug from Akeso and Summit Therapeutics improved survival in the Harmoni-6 Phase 3 trial conducted in China, according to results being presented at the American Society of ...

Lilly's upcoming label expansion proposal for 2020-approved Retevmo is "in many ways, the final chapter of the development program" for the drug, oncology head Jacob Van Naarden said in an interview. ...

Ivonescimab's landmark overall survival win against PD-1 in their chemotherapy combinations in first-line lung cancer drew both hope and criticism at ASCO 2026. (Angus Liu/Fierce Pharma) It’s the ...

CHICAGO—At the world’s largest oncology conference, Ozempic, a diabetes drug, found its way to the center of the conversation. As thousands of attendees bounced between presentations at the American ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. The Iron Lung movie based on the video game from YouTube creator ...

Norway’s Crown Princess Mette-Marit has been placed on a waiting list for a transplant due to “life-threatening chronic lung disease,” the country’s royal household has announced. The 52-year-old ...

Norway’s Crown Princess Mette-Marit has been placed on a waiting list for a lung transplant after a further ‌deterioration of her health, the royal household said in a statement on Friday. The 52-year ...